Tempest Therapeutics Reports Exit Costs

Ticker: TPST · Form: 8-K · Filed: Apr 18, 2025 · CIK: 1544227

Tempest Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyTempest Therapeutics, Inc. (TPST)
Form Type8-K
Filed DateApr 18, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: restructuring, disposal, corporate-actions

Related Tickers: TPST

TL;DR

Tempest Therapeutics (TPST) filing 8-K on exit/disposal costs. Watch for financial impact.

AI Summary

On April 17, 2025, Tempest Therapeutics, Inc. filed an 8-K report detailing costs associated with exit or disposal activities. The company, formerly known as Millendo Therapeutics, Inc. and OvaScience, Inc., is incorporated in Delaware and headquartered in Brisbane, California.

Why It Matters

This filing indicates a restructuring or winding down of certain operations, which could impact future financial performance and strategic direction.

Risk Assessment

Risk Level: medium — Filings related to exit or disposal activities often signal significant operational changes or financial distress, warranting closer scrutiny.

Key Players & Entities

  • Tempest Therapeutics, Inc. (company) — Registrant
  • Millendo Therapeutics, Inc. (company) — Former company name
  • OvaScience, Inc. (company) — Former company name
  • April 17, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • Brisbane, California (location) — Principal business address

FAQ

What specific activities are associated with the exit or disposal costs reported by Tempest Therapeutics?

The filing does not specify the exact nature of the exit or disposal activities, only that costs are associated with them.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on April 17, 2025.

What is the principal business address of Tempest Therapeutics?

The principal business address is 2000 Sierra Point Parkway, Suite 400, Brisbane, California 94005.

What are the former names of Tempest Therapeutics, Inc.?

The company was formerly known as Millendo Therapeutics, Inc. and OvaScience, Inc.

In which state is Tempest Therapeutics, Inc. incorporated?

Tempest Therapeutics, Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 18, 2025 regarding Tempest Therapeutics, Inc. (TPST).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.